We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EVCM:NASDAQEverCommerce Inc. Analysis

Data as of 2026-06-25 - not real-time

$8.80

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

EverCommerce is trading at $8.80, well below its 20‑day (9.52), 50‑day (10.53) and 200‑day (10.95) simple moving averages, signaling a bearish technical backdrop. The RSI sits at 36, hinting at mild oversold pressure, while the MACD histogram remains negative, reinforcing short‑term downside momentum. On the valuation side, the trailing P/E of 68 vastly exceeds the industry average of 36, and the DCF‑derived fair value of $6.10 suggests the stock is currently overvalued relative to intrinsic fundamentals. However, forward earnings are projected to surge (forward EPS of $0.77 vs trailing $0.13), compressing the forward P/E to 11.4 and implying a potential earnings‑driven upside toward analyst targets near $11.
Financially, the company boasts strong gross margins (77.5%) but modest operating (8.8%) and profit margins (5.5%). Debt levels are elevated (debt‑to‑equity 75%), and cash reserves cover only a fraction of total debt, raising solvency concerns. Volatility is high at 56% over the past 30 days, and beta of ~1.0 indicates market‑aligned price swings. The Fear & Greed Index at 89 (Extreme Greed) suggests market optimism may be overstated given the mixed fundamentals.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Price below all major moving averages
  • Bearish MACD and negative momentum
  • High short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Forward earnings growth compressing forward P/E
  • Support level near $8.55 offering a potential floor
  • Elevated debt load limiting upside

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Strong gross margins and SaaS subscription model
  • Potential for margin expansion with scale
  • Debt reduction and cash conversion risk

Key Metrics & Analysis

Financial Health

Revenue Growth3.60%
Profit Margin5.47%
P/E Ratio67.7
ROE3.36%
ROA2.61%
Debt/Equity75.32
P/B Ratio2.2
Op. Cash Flow$105.4M
Free Cash Flow$96.9M
Industry P/E36.5

Technical Analysis

TrendBearish
RSI36.4
Support$8.55
Resistance$11.57
MA 20$9.52
MA 50$10.53
MA 200$10.95
MACDBearish
VolumeStable
Fear & Greed Index89.23

Valuation

Fair Value$6.10
Target Price$11.21
Upside/Downside27.44%
GradeOvervalued
TypeBlend

Risk Assessment

Beta1.04
Volatility56.53%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.